Remove Clinical Research Remove Demo Remove Research
article thumbnail

Four Ideas for Pharma to Maximize the Influence of Digital Opinion Leaders in Medicine

H1 Blog

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

article thumbnail

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

H1 Blog

The recent draft by the FDA introduces additional guidelines for Diversity Action Plans aimed at improving diversity in clinical research. Quality insights make a difference and H1 has the data needed to support compliance with FDA requirements and diverse clinical trials. Find out more by requesting a demo today.

FDA 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Trials, Data, Diversity – H1’s Top 5 Diagnoses (Predictions) for Biotech and Pharma in 2024

H1 Blog

Pharmaceutical companies are on the brink of a tech revolution, and will embrace AI as a means to enhance their operations and research capabilities. In the near term, AI will be all about saving time, simplifying work processes, and knocking down language and jargon barriers in healthcare and clinical research.

Trials 64
article thumbnail

Predictive Analytics in Clinical Trials

Vial

The fields of artificial intelligence (AI) and machine learning (ML) are increasingly influencing clinical research and development (R&D). Contract research organizations (CROs) and pharmaceutical companies can leverage these cutting-edge technologies to streamline clinical trials and introduce automation in drug discovery.

article thumbnail

3 Ways CROs Can Expedite Clinical Trial Site Success

H1 Blog

Clinical Research Organizations (CROs) play an important role in the success of clinical trials. CROs & Trial Diversity Diversity is an essential element of any clinical trial’s success because it allows researchers to obtain results that accurately represent all members of a population being studied.

article thumbnail

Optimizing Clinical Data Registries: Opportunities for Diversity and Feasibility

H1 Blog

Data sharing is crucial for promoting scientific discoveries and informed decision-making in clinical practice. Without access to all the relevant data, researchers are unable to fully understand the complexities of diseases and develop effective treatments.